India capable to develop vax for any new Covid strain: ICMR
IANS -
"Currently we are not seeing any strain more virulent than the previous Omicron," Bahl said, at a press conference, noting that the virus is not gone.
Vax prior to Covid prevented post-infection deaths by 60%: ICMR study
IANS -
A team from the ICMR’s National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid in 14,419 participants.
Over 3.4mn lives saved by India's Covid vax strategy: Mandaviya
IANS -
In a virtual address of the 'The India Dialog' session on the Economic Impact of Vaccination & Related Matters, he said that for the effective management of Covid-19, the country "adopted a 'whole of government' and 'whole of society' approach in a proactive, preemptive and graded manner thus adopting a holistic response strategy". He also released a working paper.
India's first intranasal Covid vaccine iNNCOVACC launched
IANS -
iNNCOVACC is the world's first intranasal Covid-19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. It is developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance Council (BIRAC), a PSU under the Department of Biotechnology, Ministry of Science and Technology.
Centre endorses Covid-19 vaccine after-effects, but rebuts RTI reply
IANS -
An official statement on Tuesday said: "As is the case with all other vaccines, those who get vaccinated with different Covid-19 vaccines may experience mild symptoms like injection site tenderness, pain, headache, fatigue, myalgia, malaise, pyrexia, chills, arthralgia etc. Rarely, few individuals may experience severe adverse events depending upon certain pre-disposing conditions."
Centre approves Bharat Biotech's intranasal Covid vaccine for booster
IANS -
The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
India reports 185 fresh Covid cases, 1 death
IANS -
In the same period, the country has recorded one Covid related death, taking the national toll to 5,30,681 as per the report. Meanwhile, the active caseload of the country presently stands at 3,402 cases, accounting for 0.01 per cent of the country's total positive cases.
Covid vaccines manufactured by third parties, govt can't be held liable for deaths: Centre to SC
IANS -
The Centre's response came on a plea filed by the parents of two girls who had passed away owing to side-effects of the Covid vaccine. The Ministry of Health and Family Welfare, in an affidavit, said: "There is no material to suggest how the state can be fastened with strict liability for the tragic death of the respective children of the petitioners which is the requirement in law to sustain a claim for compensation against the state under Article 32 of the Constitution."
DCGI nod to Bharat Biotech's Intranasal Covid booster dose for restricted use
IANS -
As per the vaccine manufacturer, the nasal route has excellent potential for vaccination due to the organised immune systems of the nasal mucosa. Thus, intranasal immunisation of ChAd-SARS-CoV-2-S can create an immune response in the nose, which is the point of entry for the virus -- thereby protecting against disease, infection, and transmission.
India reports 1,334 fresh Covid cases, 16 deaths
IANS -
In the same period, the country has recorded 16 more Covid related deaths, taking the toll to 5,28,977, as per the report. Active caseload of the country presently stands at 23,193 cases, accounting for 0.05 per cent of the total positive cases.
Advertisement